• The patent provides additional intellectual property protection for methods that enable high-quality colonoscopy with little or no preparation
• The Company believes that reducing the burden of preoperative bowel preparation can ensure better adherence to colorectal cancer screening guidelines, particularly in the large outpatient segment of the market

FORT LAUDERDALE, Fla., Oct. 06, 2022 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., MOTS (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and increase cost efficiencies associated with the diagnosis and treatment of gastrointestinal disorders, announced today that the patent and United States Trademark Office (USPTO) has issued a new patent (Patent No. 11446428) to the company entitled “Cleaning Method for Preplose Colonoscopy.”

“Our new patent covers methods of clearing the colon in patients who have had limited or no prep with the Pure-Vu system prior to their colonoscopy in the outpatient setting,” commented Tim Moran, Chief Executive Officer of Motus GI. “We believe that our new methods, together with the previously published clinical data on limited preparatory colonoscopy using the Pure-Vu system, set the stage to address the current burden of completing the preparatory process, which is the main problem preventing people from having a colonoscopy what can help prevent colon cancer,” continued Mr. Moran.

The new patent covers methods for removing fecal matter, which consists of particles of different sizes and compositions, from the wall of a colon or other body lumen for diagnostic testing. These methods are further adapted for use in patients who have undergone limited preparation to reduce and/or sanitize the particulate structure of the colonic contents or have not undergone any preparation prior to colonoscopy.

one…